Terpenoid ID | TKC206758 |
![]() |
Chirality | TKC112756 | |
Cell line | 0 | |
Protein target | 33 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 44 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC206758 | P11473 | Vitamin D3 receptor | VDR | 56234 | nM | Potency |
TKC206758 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 29093 | nM | Potency |
TKC206758 | P15207 | Androgen receptor | Ar | 40738 | nM | IC50 |
TKC206758 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 21500 | nM | Km |
TKC206758 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 12589 | nM | Potency |
TKC206758 | Q9UNA4 | DNA polymerase iota | POLI | 89125 | nM | Potency |
TKC206758 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 100000 | nM | Potency |
TKC206758 | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | USP1 | 35481 | nM | Potency |
TKC206758 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 17783 | nM | Potency |
TKC206758 | P0DTD1 | Replicase polyprotein 1ab | rep | -1 | % | Inhibition |
TKC206758 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 25 | nM | Potency |
TKC206758 | P63096 | Guanine nucleotide-binding protein G | GNAI1 | 11220 | nM | Potency |
TKC206758 | P54132 | Bloom syndrome protein | BLM | 100000 | nM | Potency |
TKC206758 | Q01453 | Peripheral myelin protein 22 | PMP22 | 75686 | nM | Potency |
TKC206758 | Q92830 | Histone acetyltransferase KAT2A | KAT2A | 8913 | nM | Potency |
TKC206758 | P02545 | Prelamin-A/C | LMNA | 25119 | nM | Potency |
TKC206758 | O15439 | ATP-binding cassette sub-family C member 4 | ABCC4 | 3000 | nM | IC50 |
TKC206758 | Q92887 | ATP-binding cassette sub-family C member 2 | ABCC2 | 395 | % | Activity |
TKC206758 | P22309 | UDP-glucuronosyltransferase 1A1 | UGT1A1 | 0 | pm/min/mg | Activity |
TKC206758 | P22310 | UDP-glucuronosyltransferase 1A4 | UGT1A4 | 28 | pm/min/mg | Activity |
TKC206758 | O60656 | UDP-glucuronosyltransferase 1A9 | UGT1A9 | 0 | pm/min/mg | Activity |
TKC206758 | P19224 | UDP-glucuronosyltransferase 1-6 | UGT1A6 | 0 | pm/min/mg | Activity |
TKC206758 | P54855 | UDP-glucuronosyltransferase 2B15 | UGT2B15 | 0 | pm/min/mg | Activity |
TKC206758 | Q9HAW8 | UDP-glucuronosyltransferase 1A10 | UGT1A10 | 0 | pm/min/mg | Activity |
TKC206758 | Q9HAW9 | UDP-glucuronosyltransferase 1A8 | UGT1A8 | 0 | pm/min/mg | Activity |
TKC206758 | Q9HAW7 | UDP-glucuronosyltransferase 1A7 | UGT1A7 | 0 | pm/min/mg | Activity |
TKC206758 | P16662 | UDP-glucuronosyltransferase 2B7 | UGT2B7 | 0 | pm/min/mg | Activity |
TKC206758 | O35627 | Nuclear receptor subfamily 1 group I member 3 | Nr1i3 | 54 | % | Remaining activity |
TKC206758 | P04278 | Sex hormone-binding globulin | SHBG | 71 | nM | Kd |
TKC206758 | P08185 | Corticosteroid-binding globulin | SERPINA6 | 2455 | nM | Ki |
TKC206758 | P46720 | Solute carrier organic anion transporter family member 1A1 | Slco1a1 | 10600 | nM | Ki |
TKC206758 | P46720 | Solute carrier organic anion transporter family member 1A1 | Slco1a1 | 5000 | nM | Km |
TKC206758 | P56937 | 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 | HSD17B7 | 2 | % | Inhibition |
TKC206758 | Q9UNQ0 | Broad substrate specificity ATP-binding cassette transporter ABCG2 | ABCG2 | 50 | % | Activity |
TKC206758 | P0A6C1 | Endonuclease 4 | nfo | 44668 | nM | Potency |
TKC206758 | O09028 | Gamma-aminobutyric acid receptor subunit pi | Gabrp | 410 | nM | IC50 |
TKC206758 | O35913 | Solute carrier organic anion transporter family member 1A4 | Slco1a4 | 17000 | nM | Km |
TKC206758 | O88397 | Solute carrier organic anion transporter family member 1A5 | Slco1a5 | 162000 | nM | Km |
TKC206758 | P46721 | Solute carrier organic anion transporter family member 1A2 | SLCO1A2 | 6600 | nM | Km |
TKC206758 | Q9QZX8 | Solute carrier organic anion transporter family member 1B2 | Slco1b2 | 5300 | nM | Km |
TKC206758 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | 6220 | nM | EC50 |
TKC206758 | P33527 | Multidrug resistance-associated protein 1 | ABCC1 | 5000 | nM | Km |
TKC206758 | P11413 | Glucose-6-phosphate 1-dehydrogenase | G6PD | >200000 | nM | IC50 |
TKC206758 | P70502 | Solute carrier organic anion transporter family member 1A3 | Slco1a3 | 7600 | nM | Km |
TKC206758 | Q9QXZ6 | Solute carrier organic anion transporter family member 1A1 | Slco1a1 | 8200 | nM | Km |
TKC206758 | P06133 | UDP-glucuronosyltransferase 2B4 | UGT2B4 | 0 | pm/min/mg | Activity |
TKC206758 | O75795 | UDP-glucuronosyltransferase 2B17 | UGT2B17 | 5 | pm/min/mg | Activity |
TKC206758 | P36537 | UDP-glucuronosyltransferase 2B10 | UGT2B10 | 0 | pm/min/mg | Activity |
TKC206758 | P08842 | Steryl-sulfatase | STS | 1700 | nM | Km |
TKC206758 | Q96J66 | ATP-binding cassette sub-family C member 11 | ABCC11 | 13000 | nM | Km |
TKC206758 | Q9NSA0 | Solute carrier family 22 member 11 | SLC22A11 | 630 | nM | Km |
TKC206758 | O54939 | Testosterone 17-beta-dehydrogenase 3 | Hsd17b3 | 90 | nM | IC50 |
TKC206758 | Q06278 | Aldehyde oxidase | AOX1 | >100000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
O94782 | UBP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22309 | UD11_HUMAN | Inborn porphyrin/heme metabolism error [ICD-11: 5C58] |
P08185 | CBG_HUMAN | Asthma [ICD-11: CA23] |
P08185 | CBG_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P08185 | CBG_HUMAN | Respiratory system disease [ICD-11: CB40-CB7Z] |
P08185 | CBG_HUMAN | Retinopathy [ICD-11: 9B71] |
Q9UNQ0 | ABCG2_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
Q9UNQ0 | ABCG2_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
Q8TDU6 | GPBAR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 | GPBAR_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 | GPBAR_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P33527 | MRP1_HUMAN | Gout [ICD-11: FA25] |
P11413 | G6PD_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11413 | G6PD_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P11413 | G6PD_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P08842 | STS_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P08842 | STS_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P08842 | STS_HUMAN | Endometriosis [ICD-11: GA10] |
P08842 | STS_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P08842 | STS_HUMAN | Prostate cancer [ICD-11: 2C82] |
Q06278 | AOXA_HUMAN | Prostate cancer [ICD-11: 2C82] |
Q06278 | AOXA_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q06278 | AOXA_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |